Isak Nylén is Acting CEO and Country Manager of Cellcolabs, a biotechnology company specializing in the industrial GMP production of high-quality mesenchymal stromal cells (MSCs). Cellcolabs is focused on scaling stem cell manufacturing to accelerate research and expand access to next-generation regenerative therapies worldwide.
With a background in business and strategy, Isak studied at Copenhagen Business School, bringing a strong commercial and operational perspective to the rapidly evolving field of cell therapy and advanced biomanufacturing.